Escalier Biosciences

Escalier Biosciences is a new drug developer focusing on the development of small molecule RORyt-targeted inhibitors for the treatment of psoriasis and other autoimmune diseases. It aims to utilize RORyt inhibitors to reverse the secretion of pro-inflammatory cytokines by immune cells, reduce the levels of IL-17 in the human body, and thereby achieve therapeutic effects.